HAS Group Strengthens Its Focus on Talent Acquisition and Career Opportunities
HAS Group is reinforcing its commitment to attracting new talent and creating opportunities for professionals at every stage of their career. The Group has also unified the job postings of its two plants, which are now accessible through the AITI/e-lavoro platform, offering candidates a clearer and more immediate way to explore open positions, including apprenticeships, internships, and traineeships, across the organization.
More than a recruitment initiative, this approach reflects HAS Group’s intention to welcome, develop, and retain people who can contribute to its long-term growth. By making career opportunities easier to access, the Group aims to connect with motivated individuals who want to build their future in a dynamic and innovative environment.
Organic Growth and Investment in People
Since its establishment, from throughout 2025 to the present day, HAS Group has already welcomed over 30 professionals in technical, scientific and managerial roles. This commitment to workforce expansion is part of a broader five-year investment plan – officially announced last January – which allocates significant resources to organizational development, with the goal of strengthening the Group’s production, technological and commercial capabilities, particularly in the high-potency, oncology and ADC sectors.
The expansion of the workforce is an integral part of HAS Group’s growth strategy, which aims to consolidate its position as a leading global CDMO partner, keeping people at the very heart of its values.
The Values Guiding Our Search for New Talent
The Group is looking for individuals who share the core principles underlying its operations:
· Respect for every individual
· Empowerment of each person’s potential
· Quality in everything we do
· Integrity as the foundation of how we operate
· Work-life balance, because the well-being of our people stems from a healthy balance between private and professional life
Those who wish to grow in a welcoming and stimulating environment, where values are more than just words, are invited to apply.
How to Apply
All open opportunities from HAS Group’s two plants are now available through the dedicated HAS Group presence on the AITI/e-lavoro platform: https://e-lavoro.ch/node/293
If you cannot find a position currently matching your profile, you may send your CV along with a brief motivation letter to:
hasgrouprecruitment@hashealthcare.com
Applications will be carefully reviewed and kept on file for future opportunities.
About HAS Healthcare Advanced Synthesis Group
HAS Healthcare Advanced Synthesis is part of the HAS Group, an integrated CDMO platform established in 2025 through the acquisition of Cerbios–Pharma SA. Rooted in decades of Swiss precision and built on more than forty years of combined experience, the HAS Group brings together advanced chemical and biological expertise within a single, fully integrated organization.
With a robust portfolio of established APIs and pharmaceutical products, the Group delivers innovative solutions across highly specialized technologies, including Antibody–Drug
Conjugates (ADCs). This foundation reflects a long–term vision driven by scientific excellence, quality, and strong family values.
We unite complementary capabilities in chemical and biological development, specializing in APIs, HPAPIs, anticancer compounds, linker–payloads, and ADCs. Our end–to–end solutions guide projects from early–phase development through commercial supply, leveraging multiple GMP–certified sites across Switzerland. We combine scientific excellence with strategic agility to accelerate our partners’ success.
Whether advancing early–stage research or scaling for global markets, HAS Group is your trusted partner to innovate, manufacture, and deliver.
